Cargando…

Survivin is Highly Expressed and Promotes Cell Survival in Malignant Peritoneal Mesothelioma

Background: The biology of malignant peritoneal mesothelioma (MPM) is largely unknown. In the present study, we assessed the expression of survivin and other members of the inhibitors of apoptosis proteins (IAP) family (IAP-1, IAP-2 and X-IAP) in a series of 32 MPM surgical specimens and investigate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zaffaroni, Nadia, Costa, Aurora, Pennati, Marzia, De Marco, Cinzia, Affini, Emanuela, Madeo, Maria, Erdas, Roberta, Cabras, Antonello, Kusamura, Shigeki, Baratti, Dario, Deraco, Marcello, Daidone, Maria Grazia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2007
Materias:	Other
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4618413/ https://www.ncbi.nlm.nih.gov/pubmed/18032822 http://dx.doi.org/10.1155/2007/456839

Ejemplares similares

Molecular Signatures for Combined Targeted Treatments in Diffuse Malignant Peritoneal Mesothelioma
por: Belfiore, Antonino, et al.
Publicado: (2019)

Diagnostic and Therapeutic Pathway in Diffuse Malignant Peritoneal Mesothelioma
por: Kusamura, Shigeki, et al.
Publicado: (2023)

Anti-tumor activity of selective inhibitors of XPO1/CRM1-mediated nuclear export in diffuse malignant peritoneal mesothelioma: the role of survivin
por: De Cesare, Michelandrea, et al.
Publicado: (2015)

Commment on the review entitled “A critical appraisal of hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of advanced and recurrent ovarian cancer” by Chiva LM and Gonzalez-Martin A.
por: Deraco, Marcello, et al.
Publicado: (2015)

CpG-oligodeoxynucleotides exert remarkable antitumor activity against diffuse malignant peritoneal mesothelioma orthotopic xenografts
por: De Cesare, Michelandrea, et al.
Publicado: (2016)

Antitumor activity of miR-34a in peritoneal mesothelioma relies on c-MET and AXL inhibition: persistent activation of ERK and AKT signaling as a possible cytoprotective mechanism
por: El Bezawy, Rihan, et al.
Publicado: (2017)

miR-550a-3p is a prognostic biomarker and exerts tumor-suppressive functions by targeting HSP90AA1 in diffuse malignant peritoneal mesothelioma
por: El Bezawy, Rihan, et al.
Publicado: (2022)

Splicing modulation as novel therapeutic strategy against diffuse malignant peritoneal mesothelioma
por: Sciarrillo, Rocco, et al.
Publicado: (2018)

Mesothelioma
por: Deraco, Marcello
Publicado: (2021)

Epithelioid peritoneal mesothelioma: a hybrid phenotype within a mesenchymal-epithelial/epithelial-mesenchymal transition framework
por: Bozzi, Fabio, et al.
Publicado: (2016)

Complex Immune Contextures Characterise Malignant Peritoneal Mesothelioma: Loss of Adaptive Immunological Signature in the More Aggressive Histological Types
por: Tazzari, Marcella, et al.
Publicado: (2018)

Survivin expression as an independent predictor of overall survival in malignant peritoneal mesothelioma
por: Zhang, Guozun, et al.
Publicado: (2020)

Selinexor Sensitizes TRAIL-R2-Positive TNBC Cells to the Activity of TRAIL-R2xCD3 Bispecific Antibody
por: Martini, Silvia, et al.
Publicado: (2020)

GNAS mutations as prognostic biomarker in patients with relapsed peritoneal pseudomyxoma receiving metronomic capecitabine and bevacizumab: a clinical and translational study
por: Pietrantonio, Filippo, et al.
Publicado: (2016)

Peritoneal Malignant Psammomatous Mesothelioma
por: Pusiol, Teresa, et al.
Publicado: (2010)

Correlation between biological and mechanical properties of extracellular matrix from colorectal peritoneal metastases in human tissues
por: Lorenc, Ewelina, et al.
Publicado: (2023)

Decellularized extracellular matrix as scaffold for cancer organoid cultures of colorectal peritoneal metastases
por: Varinelli, Luca, et al.
Publicado: (2022)

miR-34a-Mediated Survivin Inhibition Improves the Antitumor Activity of Selinexor in Triple-Negative Breast Cancer
por: Martini, Silvia, et al.
Publicado: (2021)

Preliminary results of a program for the implementation of laparoscopic colorectal surgery in an Italian comprehensive cancer center during the COVID-19 pandemic
por: Baratti, D., et al.
Publicado: (2022)

Peritoneal mesothelioma.
por: Kealey, W. D., et al.
Publicado: (1993)

Peritoneal mesothelioma.
por: Churg, J
Publicado: (1974)

Peritoneal mesothelioma
por: Greenbaum, Alissa, et al.
Publicado: (2020)

A2AR Expression and Immunosuppressive Environment Independent of KRAS and GNAS Mutations in Pseudomyxoma Peritonei
por: Kusamura, Shigeki, et al.
Publicado: (2023)

Serum Survivin Levels and Outcome of Chemotherapy in Patients with Malignant Mesothelioma
por: Goričar, Katja, et al.
Publicado: (2015)

Benign Multicystic Peritoneal Mesothelioma in a Male Patient with Previous Wilms' Tumor: A Case Report and Review of the Literature
por: Canu, Gian Luigi, et al.
Publicado: (2018)

miR-21: an oncomir on strike in prostate cancer
por: Folini, Marco, et al.
Publicado: (2010)

Genomic landscape of pleural and peritoneal mesothelioma tumours
por: Hiltbrunner, Stefanie, et al.
Publicado: (2022)

Multicystic peritoneal mesothelioma
por: Tentes, Antonios-Apostolos, et al.
Publicado: (2012)

Malignant Peritoneal Mesothelioma
por: Fukunaga, Tomohiko, et al.
Publicado: (2022)

2022 Peritoneal Surface Oncology Group International Consensus on HIPEC Regimens for Peritoneal Malignancies: Colorectal Cancer
por: Hübner, Martin, et al.
Publicado: (2023)

Complications and Mortality Rate of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy: Italian Peritoneal Surface Malignancies Oncoteam Results Analysis
por: Carboni, Fabio, et al.
Publicado: (2022)

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer with Synchronous Peritoneal Metastases: Multicenter Study of ‘Italian Peritoneal Surface Malignancies Oncoteam—S.I.C.O.’
por: Marano, Luigi, et al.
Publicado: (2021)

Primary Peritoneal Desmoplastic Mesothelioma
por: Malla, Sundeep, et al.
Publicado: (2020)

Benign peritoneal cystic mesothelioma mimicking peritoneal tuberculosis
por: Soltani, Chayma, et al.
Publicado: (2022)

Breast Cancer-Initiating Cells: Insights into Novel Treatment Strategies
por: Santilli, Guido, et al.
Publicado: (2011)

Forecast of Malignant Peritoneal Mesothelioma Mortality in Italy up to 2040
por: Oddone, Enrico, et al.
Publicado: (2020)

Life Expectancy in Pleural and Peritoneal Mesothelioma
por: Shavelle, Robert, et al.
Publicado: (2017)

Treatment of Patients with Malignant Peritoneal Mesothelioma
por: Li, Claire Y., et al.
Publicado: (2022)

Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Metastases From a Small Bowel Adenocarcinoma: Multi-Institutional Experience
por: Liu, Yang, et al.
Publicado: (2018)

HIPEC in Peritoneal Metastasis of Gastric Origin: A Systematic Review of Regimens and Techniques
por: Gronau, Felix, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jbaao0ibmfs4i5fjebfs10opji